WI
GILD icon

Wahed Invest’s Gilead Sciences GILD Stock Holding History

Wahed Invest’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74M Sell
29,566
-1,967
-6% -$259K 0.39% 38
2026
Q1 		$4.39M Sell
31,533
-1,263
-4% -$177K 0.57% 32
2025
Q4 		$4.03M Sell
32,796
-1,276
-4% -$155K 0.53% 33
2025
Q3 		$3.78M Buy
34,072
+216
+0.6% +$24.6K 0.52% 35
2025
Q2 		$3.75M Buy
+33,856
New +$3.6M 0.57% 30
2024
Q3 		– Sell
-29,941
Closed -$2.05M – 230
2024
Q2 		$2.05M Buy
29,941
+5,485
+22% +$366K 0.41% 45
2024
Q1 		$1.79M Buy
24,456
+3,314
+16% +$255K 0.41% 47
2023
Q4 		$1.71M Buy
21,142
+1,334
+7% +$104K 0.48% 40
2023
Q3 		$1.48M Buy
19,808
+1,774
+10% +$136K 0.48% 40
2023
Q2 		$1.39M Buy
+18,034
New +$1.44M 0.49% 38
2022
Q4 		– Sell
-14,270
Closed -$880K – 245
2022
Q3 		$880K Buy
14,270
+1,018
+8% +$64.2K 0.54% 30
2022
Q2 		$819K Buy
+13,252
New +$820K 0.51% 33

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wahed Invest's GILD Position: Q2 2026 in Review

Wahed Invest reduced its Gilead Sciences (GILD) stake by 6.2% in Q2 2026, selling an estimated $259K and leaving 29,566 shares worth $3.74M. The position accounts for 0.39% of the portfolio, ranked #38.

Wahed Invest first reported a position in GILD in Q2 2022 and has held it in 12 quarters since. The position peaked at $4.39M in Q1 2026. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wahed Invest held 29,566 shares of Gilead Sciences worth $3.74M as of Q2 2026.
  • Wahed Invest sold 1,967 Gilead Sciences shares in Q2 2026, an estimated $259K.
  • Gilead Sciences made up 0.39% of Wahed Invest's portfolio in Q2 2026, its #38 holding.
  • Wahed Invest first reported a position in Gilead Sciences in Q2 2022 and has held it in 12 quarters since.
  • Wahed Invest's Gilead Sciences position peaked at $4.39M in Q1 2026.
  • 2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wahed Invest's 13F filing for Q2 2026, filed 11 Aug 2026.